EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

The Digital Diabetes Patient Reminder Tool for Adults With Type 2 Diabetes: Protocol for a Proof-of-Concept Randomized Controlled Trial

The Digital Diabetes Patient Reminder Tool für Erwachsene mit Typ-2-Diabetes: Protokoll einer Proof-of-Concept-randomisierten kontrollierten Studie

Barbara Annancy, Steve Van den Bulck, Steffen Fieuws, Laura Van den Mooter, Roman Vangoitsenhoven, Geert Goderis

JMIR Research Protocols · 22.09.2026 · 15 · e93006-e93006

DOI: 10.2196/93006 ↗

Auf einen Blick

Geplant ist ein RCT mit etwa 200 Erwachsenen mit Typ-2-Diabetes. Untersucht wird, ob die DIPAR-Erweiterung die leitliniengerechte Nachsorge verbessert.

Fragestellung

Verbessert die DIPAR-Tool-Erweiterung die Adhärenz zur empfohlenen Diabetes-Nachsorge bei Erwachsenen mit Typ-2-Diabetes?

Methode

Multizentrische, pragmatische, parallele, proof-of-concept RCT in 2 Krankenhäusern in Flandern; 1:1-randomisiert; 12 Monate Intervention; Auswertung per Intention-to-treat.

Ergebnisse

Es wurden 201 Patient:innen rekrutiert, 100 der Interventionsgruppe zugeteilt. Die Datenauswertung hat noch nicht begonnen.

Schlussfolgerung der Autor:innen

Die Studie soll Hinweise auf den möglichen zusätzlichen Nutzen eines digitalen Erinnerungstools für das T2DM-Management im Versorgungsalltag sowie auf dessen Usability und Akzeptanz liefern.

Kernaussagen

  • Primäres Ziel: mindestens 1 dokumentierte jährliche Albuminurie-Messung
  • Sekundäres Ziel: mindestens 2 dokumentierte HbA1c-Messungen in 12 Monaten
  • Usability und Akzeptanz werden per MAUQ, Interviews und Fokusgruppen geprüft

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 22.09.2026. Verfasst von Barbara Annancy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academic Center for General Practice, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 7 blok g - bus 7001, Leuven, Flanders, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Reminder Systems. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

About 828 million adults were estimated to be living with diabetes, and this is projected to affect 1 in 9 adults by 2045. In Belgium, 7.6% of adults have been diagnosed with the disease; however, approximately 1 in 3 people remain unaware of their condition. Advances in information and communication technology (ICT) have improved care quality and health management, and facilitated communication between health care providers and patients. The Digital Diabetes Patient Reminder (DIPAR) tool was developed as an extension of the existing patient portal to support diabetes management through automated reminders for overdue monitoring, and a consultation dashboard that facilitates communication between patients and health care providers. This pilot study was conducted within the European Joint Action on Cardiovascular Diseases and Diabetes framework.

Objective

This trial aims to evaluate whether the implementation of the DIPAR tool improves adherence to recommended diabetes follow-up. The primary objective is to determine whether the intervention increases the proportion of adults with type 2 diabetes mellitus (T2DM) who receive at least one documented annual albuminuria measurement in the electronic medical records (EMR). The key secondary objective is to assess whether the intervention increases the proportion of patients with at least 2 documented hemoglobin A 1c (HbA 1c ) measurements within 12 months. Exploratory objectives include evaluating changes in diabetes-related clinical parameters (HbA 1c , albuminuria, low-density lipoprotein (LDL)–cholesterol, and systolic blood pressure), as well as the usability and acceptability of the intervention among patients and health care professionals.

Methods

This multicenter, pragmatic, parallel-group, proof-of-concept randomized controlled trial (RCT) will recruit approximately 200 adults with T2DM receiving outpatient diabetes care at 2 hospitals in Flanders, Belgium. Participants will be randomized (1:1), stratified only by study center, to receive either the DIPAR tool extension in addition to usual care or usual care alone using the standard patient portal. The intervention consists of automated reminders for timely follow-up and a consultation dashboard to be used by patients and physicians. The intervention will last 12 months. Clinical outcomes will be extracted from the EMR, while usability and acceptability will be evaluated using the Dutch and English versions of the Mobile Health App Usability Questionnaire (MAUQ), semistructured interviews, and focus group discussions. The primary analysis will follow the intention-to-treat principle using regression-based methods appropriate for each outcome.

Results

Recruitment started in October 2025 and was completed in December 2025. A total of 201 patients were recruited, with 100 participants allocated to the intervention group. Data extraction did not commence until March 2026, after the completion of the statistical analysis plan and the protocol submission. Data analysis has not started.

Conclusions

This study will provide insights into the potential added value of a digital reminder tool for T2DM management in a real-world setting as well as the usability and acceptability of this tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Reminder SystemsAdultFemaleHumansMaleMiddle AgedAdherence InterventionsAlbuminuriaBelgiumDashboard SystemsDigital HealthGlycated HemoglobinPilot ProjectsProof of Concept StudyRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Digital Diabetes Patient Reminder (DIPAR)Joint Action for Cardiovascular Diseases and Diabetes (JACARDI)diabetesdigital interventioneHealthmHealthmobile health appself-careself-managementtype 2 diabetes mellitus

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Academic Center for General Practice, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 7 blok g - bus 7001, Leuven, Flanders, 3000, Belgium, 32 16330078.
  • Research Group Healthcare and Ethics, Faculty of Medicine and Life Sciences, UHasselt, Hasselt, Belgium.
  • Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), Department of Public Health and Primary Care, KU Leuven, Leuven, Flanders, Belgium.
  • Endocrinology, Department of Endocrinology And Diabetology, Regional Hospital of Tienen, Tienen, Belgium.
  • Endocrinology, Department of Endocrinology, University Hospital of Leuven, Leuven, Belgium.
  • Clinical and Experimental Endocrinology, Department of Chronic diseases and Metabolism, KU Leuven, Leuven, Flanders, Belgium.

Zitieren

APA

Annancy, B., Van den Bulck, S., Fieuws, S., Van den Mooter, L., Vangoitsenhoven, R., & Goderis, G. (2026). The Digital Diabetes Patient Reminder Tool for Adults With Type 2 Diabetes: Protocol for a Proof-of-Concept Randomized Controlled Trial. JMIR Research Protocols, 15, e93006-e93006. https://doi.org/10.2196/93006

Vancouver

Annancy B, Van den Bulck S, Fieuws S, Van den Mooter L, Vangoitsenhoven R, Goderis G. The Digital Diabetes Patient Reminder Tool for Adults With Type 2 Diabetes: Protocol for a Proof-of-Concept Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e93006-e93006. doi:10.2196/93006

BibTeX
@article{Annancy2026,
  author = {Annancy, Barbara and Van den Bulck, Steve and Fieuws, Steffen and Van den Mooter, Laura and Vangoitsenhoven, Roman and Goderis, Geert},
  title = {The Digital Diabetes Patient Reminder Tool for Adults With Type 2 Diabetes: Protocol for a Proof-of-Concept Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e93006--e93006},
  doi = {10.2196/93006}
}
Kostenlos starten →